Published in Intern Med on January 01, 2013
A unique association of arrhythmogenic right ventricular dysplasia and acute myocarditis, as assessed by cardiac MRI: a case report. BMC Cardiovasc Disord (2016) 0.77
Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA (2002) 4.48
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med (2013) 3.72
Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA (2007) 3.03
Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA (2012) 3.01
Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation (2007) 2.36
Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med (2008) 2.17
Indications for the use of diagnostic implantable and external ECG loop recorders. Europace (2009) 2.06
Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol (2012) 2.02
Electroanatomic characterization of post-infarct scars comparison with 3-dimensional myocardial scar reconstruction based on magnetic resonance imaging. J Am Coll Cardiol (2008) 2.00
Mechanisms of right atrial tachycardia occurring late after surgical closure of atrial septal defects. J Cardiovasc Electrophysiol (2005) 1.98
A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J (2012) 1.91
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2006) 1.84
Pulse wave velocity assessment by external noninvasive devices and phase-contrast magnetic resonance imaging in the obese. Hypertension (2009) 1.69
Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging (2013) 1.65
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J (2008) 1.64
A new dual-chamber pacing mode to minimize ventricular pacing. Pacing Clin Electrophysiol (2005) 1.52
Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy. Eur Heart J (2008) 1.44
Incidence and prognostic significance of spontaneous and inducible antidromic tachycardia. Europace (2012) 1.43
Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol (2005) 1.43
Isthmus characteristics of reentrant ventricular tachycardia after myocardial infarction. Circulation (2002) 1.27
Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J (2003) 1.21
Automatic home monitoring of implantable cardioverter defibrillators. Europace (2008) 1.21
Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med (2008) 1.16
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16
The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J (2009) 1.14
Sudden death in noncoronary heart disease is associated with delayed paced ventricular activation. Circulation (2003) 1.09
Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri: a multicenter study in France. Arch Intern Med (2002) 1.09
Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation (2005) 1.06
Electroanatomic mapping characteristics of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Europace (2005) 1.06
Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace (2007) 1.05
Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study. Eur J Heart Fail (2012) 1.04
Detection of myocarditis by contrast-enhanced MRI in patients presenting with acute coronary syndrome but no coronary stenosis. J Magn Reson Imaging (2007) 1.02
Venice Chart International Consensus document on ventricular tachycardia/ventricular fibrillation ablation. J Cardiovasc Electrophysiol (2010) 1.00
International consensus on nomenclature and classification of atrial fibrillation: A collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol (2003) 0.98
Cardiac device-related endocarditis caused by Paenibacillus glucanolyticus. J Clin Microbiol (2013) 0.97
In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis (2007) 0.96
Localizing the critical isthmus of postinfarct ventricular tachycardia: the value of pace-mapping during sinus rhythm. Heart Rhythm (2014) 0.96
Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction. Eur J Heart Fail (2009) 0.95
Myocardial infarction in a 45-year-old man following an anaphylactic reaction to a wasp sting. Int J Cardiol (2009) 0.95
Femoral pseudoaneurysms and current cardiac catheterization: evaluation of risk factors and treatment. Int J Cardiol (2008) 0.95
Aortocaval fistula: an uncommon cause of paradoxical embolism. J Cardiovasc Med (Hagerstown) (2012) 0.94
Diagnostic performance of a dual-chamber cardioverter defibrillator programmed with nominal settings: a European prospective study. J Cardiovasc Electrophysiol (2002) 0.94
Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing. J Am Coll Cardiol (2004) 0.92
Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol (2012) 0.92
Generalized MRI reconstruction including elastic physiological motion and coil sensitivity encoding. Magn Reson Med (2008) 0.92
Safety and efficacy of a dual chamber implantable cardioverter defibrillator capable of slow ventricular tachycardia discrimination: a randomized study. Pacing Clin Electrophysiol (2003) 0.91
Arterial foci of F-18 fluorodeoxyglucose are associated with an enhanced risk of subsequent ischemic stroke in cancer patients: a case-control pilot study. Clin Nucl Med (2011) 0.91
Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: The RD-CHF Study. Pacing Clin Electrophysiol (2007) 0.91
Intracardiac thrombus in a young man: don't forget Behçet's disease! Intern Med (2012) 0.89
Addition of a second LV pacing site in CRT nonresponders rationale and design of the multicenter randomized V(3) trial. J Card Fail (2010) 0.89
Cardiac impact of the arteriovenous fistula after kidney transplantation: a case-controlled, match-paired study. Transpl Int (2008) 0.89
Segmental omental infarction in childhood: an unusual case of left-sided location with extension into the pelvis. Pediatr Radiol (2007) 0.89
Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis (2004) 0.88
Impact of local agricultural and industrial practices on organic contamination of little egret (Egretta garzetta) eggs in the Rhone Delta, southern France. Environ Toxicol Chem (2002) 0.87
Organ dysfunction and muscular disability in myotonic dystrophy type 1. Medicine (Baltimore) (2011) 0.87
Rationale and current perspective for early rhythm control therapy in atrial fibrillation. Europace (2011) 0.87
Assessment of right ventricle volumes and function by cardiac MRI: quantification of the regional and global interobserver variability. Magn Reson Med (2011) 0.86
Aortic valve replacement for active infective endocarditis: 5-year survival comparison of bioprostheses, homografts and mechanical prostheses. Eur J Cardiothorac Surg (2009) 0.86
Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial. J Cardiovasc Electrophysiol (2014) 0.86
Is ablation of atrial flutter always safe? Pacing Clin Electrophysiol (2012) 0.85
Myocardial infarction and normal coronary arteries: the experience of the cardiology department of Sfax, Tunisia. Intern Med (2012) 0.84
Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: a prospective study. Europace (2012) 0.84
Valvular heart disease in antiphospholipid syndrome. Curr Rheumatol Rep (2013) 0.84
Features of cardiac remodeling, associated with blood pressure and fibrosis biomarkers, are frequent in subjects with abdominal obesity. Hypertension (2014) 0.83
Brucella myocarditis: a rare and life-threatening cardiac complication of brucellosis. Intern Med (2012) 0.83
Comparison of two-year outcomes in patients undergoing isolated coronary artery bypass grafting with and without peripheral artery disease. Am J Cardiol (2009) 0.82
A stepwise approach to the management of postinfarct ventricular tachycardia using catheter ablation as the first-line treatment: a single-center experience. Circ Arrhythm Electrophysiol (2013) 0.82
Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy. Pacing Clin Electrophysiol (2013) 0.82
Is isoproterenol really required during electrophysiological study in patients with Wolff-Parkinson-White syndrome? J Electrocardiol (2013) 0.82
Residual viability is a predictor of the perfusion enhancement obtained with the cell therapy of chronic myocardial infarction: a pilot multimodal imaging study. Clin Nucl Med (2012) 0.81
Simple and efficient identification of conduction gaps in post-ablation recurring atrial flutters. Europace (2006) 0.81
Enhanced specificity of a dual chamber ICD arrhythmia detection algorithm by rate stability criteria. Pacing Clin Electrophysiol (2004) 0.80
The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial. Eur Heart J (2015) 0.80
Heart rate variability before ventricular arrhythmias in patients with coronary artery disease and an implantable cardioverter defibrillator. Ann Noninvasive Electrocardiol (2003) 0.80
Noninvasive quantitation of blood flow turbulence in patients with aortic valve disease using online digital computer analysis of Doppler velocity data. J Am Soc Echocardiogr (2003) 0.79
Recall alerts in implantable cardioverter-defibrillator recipients: implications for patients and physicians. Pacing Clin Electrophysiol (2010) 0.79
Prospective European survey on atrial fibrillation ablation: clinical characteristics of patients and ablation strategies used in different countries. J Cardiovasc Electrophysiol (2014) 0.78
Nitrate-enhanced gated SPECT in patients with primary angioplasty for acute myocardial infarction: evidence of a reversible and nitrate-sensitive impairment of myocardial perfusion. Eur J Nucl Med Mol Imaging (2007) 0.78